期刊
CLINICAL RESEARCH IN CARDIOLOGY
卷 109, 期 10, 页码 1197-1222出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00392-020-01636-7
关键词
Cardio-oncology; Cardiotoxicity; Survivorship programs; Cancer therapy; Chemotherapy
资金
- Projekt DEAL
The acute and long-lasting side effects of modern multimodal tumour therapy significantly impair quality of life and survival of patients afflicted with malignancies. The key components of this therapy include radiotherapy, conventional chemotherapy, immunotherapy and targeted therapies. In addition to established tumour therapy strategies, up to 30 new therapies are approved each year with only incompletely characterised side effects. This consensus paper discusses the risk factors that contribute to the development of a potentially adverse reaction to tumour therapy and, in addition, defines specific side effect profiles for different treatment groups. The focus is on novel therapeutics and recommendations for the surveillance and treatment of specific patient groups.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据